FDA Inspection 784597 — Noven Pharmaceuticals, Inc.

Noven Pharmaceuticals, Inc. — FEI 1000222037

The FDA completed an inspection of Noven Pharmaceuticals, Inc. on Jun 4, 2012 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 4, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.